Ribosomal protection as a linezolid resistance mechanism in Mycobacterium abscessus

Area of Science:

• Microbiology
• Molecular Biology
• Drug Discovery

Background:

• Mycobacterium abscessus is a significant pulmonary pathogen known for drug resistance.
• Linezolid shows clinical efficacy in M. abscessus infections, but resistance mechanisms are unclear.
• ATP-binding cassette (ABC) family proteins, specifically ABC-F, are implicated in bacterial antibiotic resistance.

Purpose of the Study:

• To investigate the mechanisms of linezolid resistance in Mycobacterium abscessus.
• To identify specific proteins in M. abscessus responsible for conferring resistance to ribosome-targeting antibiotics.

Main Methods:

• Bioinformatic analysis to identify potential ABC-F proteins in M. abscessus.
• Genetic manipulation (e.g., gene knockout or overexpression) to assess the role of MAB_2736c in antibiotic resistance.
• Testing the susceptibility of M. abscessus strains with altered MAB_2736c expression to various antibiotics.

Main Results:

• An ABC-F protein, designated MAB_2736c, was identified in Mycobacterium abscessus.
• MAB_2736c was shown to confer resistance specifically to antibiotics targeting the 50S ribosomal subunit.
• This resistance includes clinically relevant drugs such as linezolid, macrolides, and chloramphenicol.

Conclusions:

• MAB_2736c is a key determinant of intrinsic resistance to multiple ribosome-targeting antibiotics in M. abscessus.
• Targeting ABC-F proteins presents a potential strategy to overcome antibiotic resistance in mycobacterial infections.
• Understanding MAB_2736c function could inform the development of novel therapeutic approaches for M. abscessus pulmonary disease.